Head-to-head · WeighScore
FuturHealth vs He & She MD
By GLP-1 ScorecardUpdated
Score comparison
He & She MD has the higher recorded score — 71.5/100 to 65.6/100.
He & She MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. He & She MD is a nationwide telehealth weight-loss clinic offering doctor-prescribed GLP-1 medications: compounded semaglutide and tirzepatide (injectable or oral), with brand-name…
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | FuturHealth | He & She MD |
|---|---|---|
| WeighScore | 65.6/100 | 71.5/100 |
| Grade | C | C |
| Site position | #241 | #101 |
| Semaglutide | $199/mo (compounded) | $199/mo (month to month, compounded; every lower rate is a prepaid term) |
| Tirzepatide | Not disclosed | $299/mo (month to month, compounded; every lower rate is a prepaid term) |
| Coverage | Coverage not published | All states except Louisiana (GLP-1) |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #241 · C
Strengths
- LegitScript Certified and HITRUST Certified
- Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
- Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
- Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths
What to consider
- Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
- BBB complaints describe recurring charges without medication received — confirm cancellation flow first
- Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
- Pricing not shown until after the qualification questionnaire or portal login
- Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Site position #101 · C
Strengths
- Publishes a full four-term price ladder for both molecules before any intake: semaglutide $199/$149/$139/$99 a month and tirzepatide $299/$209/$199/$159, with the amount actually charged shown beside each
- Compounded semaglutide and tirzepatide (injectable or oral) plus brand access to Ozempic, Wegovy, Zepbound
- Only charged if medication is prescribed; no hidden fees
- Free expedited shipping and unlimited board-certified clinician access
- GLP-1 coaching, nutrition guidance, and in-app progress tracking
What to consider
- Its own FAQ says the pharmacy it names holds a license in 44 US states, none in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia or Delaware, and “cannot dispense sterile compounds” — while the same FAQ says GLP-1s ship everywhere except Louisiana. Injectable GLP-1s are sterile compounds, and the site never says which of its two pharmacies covers the gap
- Compounded GLP-1s are not FDA-approved finished products (per the site FDA disclaimer)
- Does not ship to Louisiana or to PO boxes
- Every figure below the month-to-month rate is a prepaid block, not a running discount: the cheapest semaglutide rate is $1,188 charged once for the year, and the cheapest tirzepatide rate is $1,908
- Cash-pay model — insurance billing not indicated
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.